SCHEMBL14928530

SCHEMBL14928530

CC[C@H]([C@@H](C)CC)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.50
LMNA P02545 2/20 0.45
CASP3 P42574 1/20 0.41
ALDH1A1 P00352 6/20 0.41
HTT P42858 2/20 0.41
GAA P10253 2/20 0.40
TP53 P04637 2/20 0.40
NPC1 O15118 1/20 0.40
KDM4E B2RXH2 1/20 0.39
GLA P06280 1/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
HPGD P15428 1/20 0.39
ALOX12 P18054 1/20 0.39
NFKB1 P19838 1/20 0.39
APEX1 P27695 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14928805 0.88 TDP1 (0.46) TDP1LMNACASP3ALDH1A1HTT
SCHEMBL14928346 0.87 TDP1 (0.51) TDP1LMNACASP3ALDH1A1HTT
SCHEMBL14928969 0.87 TDP1 (0.51) TDP1LMNACASP3ALDH1A1HTT
SCHEMBL16215484 0.84 TDP1 (0.49) TDP1LMNACASP3ALDH1A1HTT
SCHEMBL14928782 0.83 TDP1 (0.51) TDP1LMNACASP3ALDH1A1HTT
SCHEMBL14928399 0.83 TDP1 (0.51) TDP1LMNACASP3ALDH1A1HTT
SCHEMBL29459229 0.79 TDP1 (0.65) TDP1LMNACASP3ALDH1A1HTT
SCHEMBL6127956 0.79 TDP1 (0.65) TDP1LMNACASP3ALDH1A1HTT
SCHEMBL14570441 0.79 TDP1 (0.65) TDP1LMNACASP3ALDH1A1HTT
SCHEMBL8938082 0.77 TDP1 (0.46) TDP1LMNACASP3ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051310-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2015-06-09 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-10-16 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK TDP1 2598/4885LMNA 3649/4885CASP3 3790/4885
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, BTK, NOX4 TDP1 1179/4885LMNA 4440/4885CASP3 3860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.